Development and validation of a universal esophageal patient-reported outcome measure: The Cleveland Clinic Esophageal Questionnaire (CEQ)

• Published in: The Journal of thoracic and cardiovascular surgery Vol. 167; no. 4; pp. 1490 - 1497.e17
• Main Authors: Sudarshan, Monisha, Tasnim, Sadia, Ramji, Sadhvika, Rappaport, Jesse, Barron, John O., Bribriesco, Alejandro C., Schraufnagel, Dean P., Lapin, Brittany, Li, Yadi, Raymond, Daniel P., Blackstone, Eugene H., Murthy, Sudish C., Raja, Siva
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2024
• Subjects: achalasia; Ambulatory Care Facilities; Esophageal Achalasia; esophageal cancer; esophageal diseases; Esophageal Diseases - diagnosis; Female; Hernia, Hiatal; hiatal hernia; Humans; Male; Patient Reported Outcome Measures; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; symptoms scale; validation; FACT-E; esophageal cancer; esophageal diseases; hiatal hernia; PROM; ICC; symptoms scale; achalasia; CEQ; QoL; SD; quality of life; validation
• ISSN: 0022-5223; 1097-685X
• DOI: 10.1016/j.jtcvs.2023.08.032

Currently, there is no validated patient-reported outcome measure (PROM) applicable to all esophageal diseases. Our objective was to create a psychometrically robust, validated universal esophageal PROM that can also objectively assess patients’ quality of life (QoL). The pilot PROM constructed based on expert opinions, literature review, and previous unpublished institutional research had 27 items covering 8 domains. It was completed by 30 patients in the outpatient clinic followed by a structured debriefing interview, which allowed for refining the PROM. The final PROM: Cleveland Clinic Esophageal Questionnaire (CEQ) included 34 items across 6 domains (Dysphagia, Eating, Pain, Reflux & Regurgitation, Dyspepsia, Dumping), each accompanied by a corresponding QoL component. Further psychometric assessment of the PROM was conducted by evaluating (1) acceptability, (2) construct validity, (3) reliability, and (4) responsiveness. Five hundred forty-six unique patients (median 63.7 years [54.3-71.7], 53% male [287], 86% White) completed CEQ at >90% completion within 5 minutes. Construct validity was demonstrated by differentiating scores across esophageal cancer (n = 146), achalasia (n = 170), hiatal hernia (n = 160), and other diagnoses (n = 70). Internal reliability (Cronbach alpha 0.83-0.89), and test–retest reliability (intraclass correlation coefficients 0.63-0.85) were strong. Responsiveness was demonstrated through CEQ domains improving for 53 patients who underwent surgery for achalasia or hiatal hernia (Cohen d 0.86-2.59). We have constructed a psychometrically robust, universal esophageal PROM that allows concise, consistent, objective quantification of symptoms and their effect on the patient. The CEQ is valuable in prognostication and tracking of longitudinal outcomes in both benign and malignant esophageal diseases. A Novel Esophageal PROM: CEQ. [Display omitted]